The panel focused on exploring how new, innovative technologies are improving medication adherence and clinical outcomes for patients with depression.
New York, NY – On May 6th, AllazoHealth CEO, Clifford Jones, appeared at this year’s American Psychiatric Association Annual Meeting as a member of a Takeda-sponsored panel. The panel, titled “Enhanced patient support and engagement through digital innovation and artificial intelligence to improve adherence and clinical outcomes,” explored how new, innovative technologies are being deployed to improve medication adherence and clinical outcomes for patients. Notably, the panel discussed innovative work that leverages technology to improve medication adherence and empower patients.
The panel was moderated by Tom Barritt (Partner and Managing Director, Ketchum) and other panelists included Mary Giliberti (NAMI CEO), Jay Fawver, M.D. (Medical Director Parkview Physicians Group Mind-Body Medicine, Fort Wayne, IN), Michael Oleksiw (Pleio CEO), and Ben Fehnert (Cofounder-Cognition Kit).